Acro Biomedical (ACBM) Short term Debt (2016 - 2022)

Acro Biomedical's Short term Debt history runs 7 years deep, the most recent figure standing at $78826.0 for Q4 2022.

• In Q4 2022, Short term Debt rose 280.05% year-over-year to $78826.0; the TTM figure through Dec 2022 stood at $78826.0 (up 280.05% YoY), while the FY2022 annual figure was $78826.0, up 280.05% from the prior year.
• Short term Debt was $78826.0 for Q4 2022 at Acro Biomedical, roughly flat from $78594.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $257567.0 in Q1 2021 to a low of $3266.0 in Q4 2018.
• Historically, Short term Debt has averaged $86005.2 across 5 years, with a median of $70306.0 in 2020.
• Biggest YoY gain for Short term Debt was 994.08% in 2018; the steepest drop was 92.11% in 2018.
• A 5-year view of Short term Debt shows it stood at $3266.0 in 2018, then surged by 704.62% to $26279.0 in 2019, then soared by 824.51% to $242951.0 in 2020, then sank by 91.46% to $20741.0 in 2021, then surged by 280.05% to $78826.0 in 2022.
• The last three Short term Debt figures came in at $78826.0 (Q4 2022), $78594.0 (Q3 2022), and $21245.0 (Q2 2022), per Business Quant data.